We are live on ! Find out more
CELG

Celgene Corp
CELG

Delisted

CELG was delisted on the 20th of November, 2019.

1,277 hedge funds and large institutions have $62.6B invested in Celgene Corp in 2016 Q3 according to their latest regulatory filings, with 122 funds opening new positions, 486 increasing their positions, 493 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more first-time investments, than exits

New positions opened: 122 | Existing positions closed: 47

12% more funds holding in top 10

Funds holding in top 10: 7483 (+9)

5% more funds holding

Funds holding: 1,2181,277 (+59)

4% more capital invested

Capital invested by funds: $60.3B → $62.6B (+$2.35B)

1% less call options, than puts

Call options by funds: $940M | Put options by funds: $952M

1% less repeat investments, than reductions

Existing positions increased: 486 | Existing positions reduced: 493

Holders
1,277
Holders Change
+59
Holders Change %
+4.84%
% of All Funds
34.07%
Holding in Top 10
83
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+12.16%
% of All Funds
2.21%
New
122
Increased
486
Reduced
493
Closed
47
Calls
$940M
Puts
$952M
Net Calls
-$12.5M
Net Calls Change
+$7.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Norges Bank
26
Norges Bank
Norway
$556M +$1.76M +16,282 +0.3%
Winslow Capital Management
27
Winslow Capital Management
Minnesota
$543M -$15.8M -146,105 -3%
Wellington Management Group
28
Wellington Management Group
Massachusetts
$526M -$317M -2,933,416 -37%
Morgan Stanley
29
Morgan Stanley
New York
$491M +$26.8M +247,342 +6%
AAMU
30
Amundi Asset Management US
Massachusetts
$480M +$40.3M +372,745 +9%
Goldman Sachs
31
Goldman Sachs
New York
$439M -$34.8M -321,476 -7%
AIM
32
abrdn Investment Management
United Kingdom
$389M -$39.7M -366,417 -9%
EVM
33
Eaton Vance Management
Massachusetts
$367M +$73.5M +679,379 +24%
PI
34
Putnam Investments
Massachusetts
$367M -$41.4M -382,689 -10%
BB
35
BB Biotech
Switzerland
$362M -$16.2M -150,000 -4%
Polen Capital Management
36
Polen Capital Management
Florida
$358M +$12.8M +118,377 +4%
ClearBridge Investments
37
ClearBridge Investments
New York
$351M +$24.1M +222,756 +7%
Legal & General Group
38
Legal & General Group
United Kingdom
$350M +$3.47M +32,068 +1%
AllianceBernstein
39
AllianceBernstein
Tennessee
$348M +$35.2M +325,653 +11%
O
40
OrbiMed
New York
$308M +$58.9M +543,900 +23%
UBS Group
41
UBS Group
Switzerland
$298M +$378K +3,491 +0.1%
Macquarie Group
42
Macquarie Group
Australia
$296M -$395M -3,653,898 -56%
State Farm Mutual Automobile Insurance
43
State Farm Mutual Automobile Insurance
Illinois
$293M
CS
44
Credit Suisse
Switzerland
$284M +$33.1M +305,737 +13%
Prudential Financial
45
Prudential Financial
New Jersey
$278M -$862K -7,968 -0.3%
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$277M +$14M +129,371 +5%
PPA
47
Parametric Portfolio Associates
Washington
$266M -$6.4M -59,091 -2%
Charles Schwab
48
Charles Schwab
California
$256M +$5.23M +48,304 +2%
O
49
OppenheimerFunds
New York
$244M +$146M +1,351,007 +138%
Sumitomo Mitsui Trust Group
50
Sumitomo Mitsui Trust Group
Japan
$243M -$17.7M -163,778 -7%

CELG Hedge Fund Activity: Q3 2016 in Review

1,277 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q3 2016, worth a combined $62.6B — up 3.9% from $60.3B a quarter earlier.

Buyers outnumbered sellers: 122 funds opened new CELG positions and 47 closed out — a net gain of 75 holders — while 486 added to existing stakes and 493 trimmed.

The largest buyer was Jennison Associates, adding an estimated $213M. The largest seller was Fidelity Investments, cutting an estimated $940M.

  • 1,277 institutional investors held Celgene Corp (CELG) as of Q3 2016, up from 1,218 in Q2 2016.
  • Funds reported $62.6B of Celgene Corp stock for Q3 2016, up 3.9% quarter-over-quarter.
  • 122 funds opened new Celgene Corp positions in Q3 2016 and 47 closed out, a net change of +75 holders.
  • The largest Celgene Corp buyer in Q3 2016 was Jennison Associates, an estimated $213M added.
  • The largest Celgene Corp seller in Q3 2016 was Fidelity Investments, an estimated $940M sold.

Based on aggregated 13F filings for Q3 2016.